Botulinum Neurotoxin Type A (BoNT-A) in Paediatric Non-neurogenic Therapy Resistant Overactive Bladder (OAB)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
A non-intervention cohort study on the use of Botulinum Neurotoxin Type A (BoNT-A) in Paediatric Non-neurogenic Therapy Resistant Overactive Bladder (OAB). Primary endpoint was the reduction of urinary incontinence.
Epistemonikos ID: c28cd367d92e6e9960b4a77b2aa7a8005be37b1d
First added on: Sep 01, 2024